Emulating from the success of the 2015 sell-out event, Pre-Filled Syringes - East Coast, returns to Iselin, New Jersey, USA for its 3rd annual show in April 2016.
With the growing demand for biologics and ready-to-administer syringes, recent reports have predicted the global pre-filled syringes (PFS) market to reach $6.6bn by 2020. While the PFS industry has witnessed booming investment, it still needs to overcome a number of hurdles.
Through a combination of powerful keynote addresses, topical debate and interactive workshops, Pre-Filled Syringes East Coast will once again play host to an audience of senior scientists, device manufacturers and PFS professionals, providing a focal point to discuss the latest innovations; as well as honing in on industry challenges and regulatory compliance.
Speakers include:
鈥� Stephen Barat, Executive Dir, Non-Clinical & Translational Sciences, Safety Assessment & Bioanalysis, Allergan
鈥� Mathias Romacker, Senior Dir, Device Strategy, Pfizer
鈥� Dr. Paolo Mangiagalli, Senior Dir, Head PFS Platform, Sanofi
鈥� Ken Wong, Deputy Director, MTech/ Process Technology 鈥� Extractables & Leachables, Sanofi Pasteur
鈥� Carsten Worsoe, Principal Scientist, CMC Analytical Support, Novo Nordisk A/S
鈥� Dr. Shawn Davis, Principal Engineer, Device Strategy, Amgen
鈥� Mohammed Umar, Principal Technical Manager, Quality Engineering, Genentech
鈥� Jason Lipman, Associate Dir, Regulatory Affairs, Medical Devices & Combination Products, Janssen R&D, LLC
Reasons to attend:
鈥� Discover how to eliminate extractables & leachables (E&L)
鈥� Incorporate human factor engineering into a patient-centric device
鈥� Ensure commercial competitiveness of PFS as a drug device
鈥� Assess trends of combination products and impacts on PFS
鈥� Learn about the latest cutting edge technological developments in COP and sterilization
鈥� Exclusive workshops led by Cambridge Consultants and FDAPharma Cosulting LLC
Price
Conference + 2 Workshops: USD 2997
Conference + 1 Workshop: USD 2398
Conference Only: USD 1799
With the growing demand for biologics and ready-to-administer syringes, recent reports have predicted the global pre-filled syringes (PFS) market to reach $6.6bn by 2020. While the PFS industry has witnessed booming investment, it still needs to overcome a number of hurdles.
Through a combination of powerful keynote addresses, topical debate and interactive workshops, Pre-Filled Syringes East Coast will once again play host to an audience of senior scientists, device manufacturers and PFS professionals, providing a focal point to discuss the latest innovations; as well as honing in on industry challenges and regulatory compliance.
Speakers include:
鈥� Stephen Barat, Executive Dir, Non-Clinical & Translational Sciences, Safety Assessment & Bioanalysis, Allergan
鈥� Mathias Romacker, Senior Dir, Device Strategy, Pfizer
鈥� Dr. Paolo Mangiagalli, Senior Dir, Head PFS Platform, Sanofi
鈥� Ken Wong, Deputy Director, MTech/ Process Technology 鈥� Extractables & Leachables, Sanofi Pasteur
鈥� Carsten Worsoe, Principal Scientist, CMC Analytical Support, Novo Nordisk A/S
鈥� Dr. Shawn Davis, Principal Engineer, Device Strategy, Amgen
鈥� Mohammed Umar, Principal Technical Manager, Quality Engineering, Genentech
鈥� Jason Lipman, Associate Dir, Regulatory Affairs, Medical Devices & Combination Products, Janssen R&D, LLC
Reasons to attend:
鈥� Discover how to eliminate extractables & leachables (E&L)
鈥� Incorporate human factor engineering into a patient-centric device
鈥� Ensure commercial competitiveness of PFS as a drug device
鈥� Assess trends of combination products and impacts on PFS
鈥� Learn about the latest cutting edge technological developments in COP and sterilization
鈥� Exclusive workshops led by Cambridge Consultants and FDAPharma Cosulting LLC
Price
Conference + 2 Workshops: USD 2997
Conference + 1 Workshop: USD 2398
Conference Only: USD 1799
